288
Participants
Start Date
January 31, 2005
Primary Completion Date
May 31, 2005
Study Completion Date
May 31, 2005
GW685698X
GSK Investigational Site, Rockville
GSK Investigational Site, Baltimore
GSK Investigational Site, Raleigh
GSK Investigational Site, Orangeburg
GSK Investigational Site, Lawrenceville
GSK Investigational Site, Lilburn
GSK Investigational Site, Tallahassee
GSK Investigational Site, Vero Beach
GSK Investigational Site, Miami
GSK Investigational Site, Miami
GSK Investigational Site, Tampa
GSK Investigational Site, Canton
GSK Investigational Site, Cincinnati
GSK Investigational Site, South Bend
GSK Investigational Site, West Allis
GSK Investigational Site, St Louis
GSK Investigational Site, St Louis
GSK Investigational Site, Omaha
GSK Investigational Site, Lincoln
GSK Investigational Site, Metairie
GSK Investigational Site, Little Rock
GSK Investigational Site, Oklahoma City
GSK Investigational Site, New Braunfels
GSK Investigational Site, Austin
GSK Investigational Site, Colorado Springs
GSK Investigational Site, Murray
GSK Investigational Site, Los Angeles
GSK Investigational Site, San Diego
GSK Investigational Site, San Diego
GSK Investigational Site, Mission Viejo
GSK Investigational Site, Orange
GSK Investigational Site, Lake Oswego
GSK Investigational Site, Eugene
GSK Investigational Site, Medford
GSK Investigational Site, Portland
GSK Investigational Site, North Andover
GSK Investigational Site, North Dartmouth
GSK Investigational Site, Springfield
GSK Investigational Site, Ocean City
GSK Investigational Site, Summit
GSK Investigational Site, Providence
GSK Investigational Site, Nashville
GSK Investigational Site, South Burlington
GSK Investigational Site, Kelowna
GSK Investigational Site, Vancouver
GSK Investigational Site, Mississauga
GSK Investigational Site, Ottawa
GSK Investigational Site, Québec
GSK Investigational Site, Saskatoon
Lead Sponsor
GlaxoSmithKline
INDUSTRY